Reddit Posts
Three Bio Plays that can be major runners for 2022: $ENVB, $XCUR and $TALK
Three Bio Plays that can be major runners for 2022: $ENVB, $XCUR and $TALK
Three Bio Plays that can be major runners for 2022: $ENVB, $XCUR and $TALK
$CYRN may be the next buyout like $TLMD - I kept saying TLMD was undervalued before but never bought as it kept dropping. CYRN same movement as TLMD same institutional owners.
$SEAC could do a $TLMD move 300% overnight imo this algo looks off.
Wtf is this market. $TLMD - So SOC Telemed completes Acquisition of Access Physicians To Form Largest Acute Care Telemedicine Company in the US but now it’s market cap doesn’t even reflect it 😆 this at $1.32 is as stupidly undervalued as $TALK is rn trading at cash! What is going on?!
TLMD squeeze? Lots of volume today and running…..up over 10%
Ya retards need to get your brains checked.
Mentions
I think when TLMD got bought out, the warrants went for like .80. TLMD commons were trading at $1 before the buyout offer.
I just tripled my position the other day at 24.5 cents and then the next day the filing came out and it went straight to 17 cents. Can't win. But I did this with TLMD I averaged down when warrants were 10 cents and then the buyout at $3 came out and the Black Scholes took the warrants to 70 cents. I barely broke even but that's what I'm banking on here since I paid over a dollar for my original position.
Still holding DMS warrants and was lucky I lowered my TLMD cost basis by adding a week before the buyout at .10. Sold all of TLMD warrants for a small loss and was just happy to get out even if your BSM works out to higher I was happy getting close to my cost basis. With DMS I'm thinking of doing the same cost basis lowering as it feels very much like it will take a similar path.
Yes, the way you have described it is exactly how I interpret it by reading the warrant agreement. And not only am I warrant holder of DMS, I have looked into this extensively. I have also modeled the black scholes value of DMS and TLMD for comparison as DMS is undergoing a strategic review and may be taken private. TLMD 90 day volatility was around ~110% prior to the announcement because it was beaten down hard and fast, thus increasing the black scholes value. DMS 90 day volatility as of today is closer to ~65%. PAE just underwent a take private and had a similar warrant clause but not exact same as DMS/TLMD HOWEVER, the biggest flaw in my analysis is that this warrant cannot be modeled using a regular BSM model due to the warrants having the redemption trigger (trading over $18 for 20 of 30 trading days). Theoretically it would be 30 days then company issues the redemption and gives holders 30 days until expiration. Over 60 days, the stock could shoot far past $18 so the warrants can really rip if a company does super well, but still the redemptions limit the upside potential Given, this, the warrants do not provide unlimited upside through the remaining term and should be penalized because of this. As a result, the calculation in the warrant agreement is the black scholes capped call option which is a modified black scholes. This type of modeling is much more advanced and beyond my abilities However, the capped call matters less the farther way you are from $18 so for the case of TLMD and now DMS, I’d argue a regular BSM is likely close to the price but the capped call should still have a rough haircut.
One of my favorite tools on this sub. Great stuff here u/mrdfw84 I still like the TLMD play, but outside of that...question marks everywhere.
Depends on the type of deal. If it's an all cash deal you'll make a shit load since you get paid close to the Black-Scholes value. ( Most warrant agreements should have this clause). See PAE, TLMD. If it's a stock for stock deal, they'll get converted into the other company's warrants and then they'll trade according to the prospect of the other company. See MILE-LMND. Market clearly doesn't like LMND's prospects.
I'm with you all the way on DMS and have been since DA dropped with Leo. I was super underwater with TLMD warrants and averaged down when they were 9 cents and got bought out last week. I ended up selling for only a slight loss but I instantly had vibes that this is going to happen soon to DMS as well. Will look to average down this week instead of wasting more money on pre-DA lotto tickets.
Look at comps... they are trading at 0.6x revenue and they are profitable... 95% of the shares are privately held and the float is tiny and insignificant. The float / public shares could be trading at $2, wouldn't affect the acquisition price. I think earlier this week TLMD was at $0.60 and was acquired / went private at $3.00 a share.
MILE was an all stock acquisition by LMND while TLMD is an all cash deal. Looking through the warrant agreement for TLMD as to what happens in a cash-based acquisition *I believe* that TLMD warrant holders are entitled to the Black Scholes value of the warrants based on a price of $3 for the underlying (the buyout price) and a volatility input based on the 90 day Historical Volatility (around 80% currently). If you put those numbers into a black scholes calculator you get around $0.74 which is almost exactly what the warrants traded at today.
TLMD buyout: did it have a warrant clause or cashless warrant price??
Pardon me if this has been brought up earlier (busy all day) but anyone sell their TLMD warrants of by some crazy chance you still were holding? I sold out at 70 cents at a bit of a loss but feel like I got lucky it got back there at all. I’m wondering if they could go up more if a different buyer steps in.
I got lucky on this one. I was -80% on TLMD warrants and doubled down at $0.10, because, why not? Flipped green two days later. I'll take a win in a sea of losses anyway I can get it!
Well, they aren't going to get Metro Mile'd... DMS is profitable / very very unlikely to sell under $11. I think they will moon, which is why I'm yolo'd into them obviously. TLMD warrants went from $0.10 to $0.80 today, so it's not like warrant holders always get screwed in buyouts, but it is possible when the company is desperate like MetroMile.
Right, and when your stock drops this low, there's not much you can do about it even if you dont want to sell. TLMD's board wasnt going to turn down a 350% premium. Given SNAX's brass prior history selling companies, I'm sure they want to sell, but probably in their mind at $12 or $15 like the analyst report's valuations. Well guess what, if Pepsi or Nabisco comes along tomorrow and offers $8 a share it's pretty tough for the board to turn down a > 200% premium.
I doubt anyone holding but could start seeing more stuff like this. DeSPAC TLMD to be acquired by Patient Square Capital for $3 per share. Commons closed at .64 yesterday. [Link](https://www.prnewswire.com/news-releases/soc-telemed-to-be-acquired-by-patient-square-capital-301474627.html)
Wonder who's up next? It'd have to be something with revenue like Uph, Body, Snax, Avpt? Maybe DNA if double booked rev counts. $TLMD ($HCCO) SOC Telemed to be Acquired by Patient Square Capital. $3 a share here, Pae acquired for 10ish recently too.
Tell me TLMD will recover. Just like to me.
buy TLMD it can't go to zero
Don't forget about TLMD. Barely over $1
How can NKLA be included when it's still at $10. ATIP, MILE, BODY, PSFE, TLMD, HYMC the list goes on
TLMD. Had a target of $7.50 - 8 when I first bought at ~$5.50. Now it's below $2 hehe
Thanks I didn’t know about this ETF, I had a look at the composition, it has TLMD and OTRK. It might be safer to get an ETF but I like risk/return duo!
What you guys think of telehealth industry ? I have research several stocks: $UPH $TLMD $LFMD $AUGX $OTRK $DRIO The first two I could create a quick and dirty (quick PE model) valuation giving me a range of $5-$7 and it follows analysts price target. Of course we should not follow at all points analysts but it sure helps to see if we are deriving a valuation alike. Though telehealth was good during the pandemic, do you think the US market will grow bigger on that after the end of the pandemic?
TLMD warrants were not adjusted. They only raised $44.6M in their May secondary offering. Like most crescent terms, TLMD's specifies that the "the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions)." The SPAC delivered $232M in proceeds to Telemed ($64M trust net redemptions, 168M PIPE), so this secondary offering would fail to trigger the crescent. Seems to me that the company can easily get around the crescent term by doing multiple small equity raises. If I'm the company, I don't care about warrant holders
Interesting point. It was my understanding that crescent terms only dealt with PIPEs below $10, but I could be wrong. TLMD is one that did an equity raise a while ago. Could that be an example where warrants are adjusted?
I am a bot. You submitted a picture of a banned ticker, TLMD. This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
$TLMD got beaten down on lower guidance but still had great revenue and beat expectations. Complete overreaction selloff. Bound to bounce back tomorrow morning.
TLMD getting added to the Russel in July
Check out TLMD for Russell rebalance. Small float, projected 5.3mm shares to buy (\~7.2 average daily volume past 20 days). This should run just like the other deSPACs into Russell rebalance end of month. Has yet to move since recent secondary in April.
Got curious, so checked out all 39 completed SPACs. There were only two out of the 39 which dropped right after merger: TLMD and ALTG. Some were high and went down to a more reasonable level, but those were the only two which dropped straight down without having a bump to at least $11 - and both are in much more precarious positions. QuantumScape is a better comparison - granted I don't expect a rocket to 120 but it's still sitting at a really big premium to NAV and rode in the 20's / high teens for a while after merger and their production won't begin till 2024....
The warrants are actually worth a dabble at their current price (\~$1.1) if you can stomach some higher risk (or at least higher volatility). If the deal closes, it's be almost impossible to lose money on them; several former SPACs, like LOTZ and TLMD, have common shares trading around $5-6 and their warrants are consistently above $1. For a stock that's around $8.5, the warrants would be in the $1.7-$2 range.
I used to think that way, and this coming from somebody who shorted a stock once (TLMD). When I made that short, however, I completely forgot the predatory financing of pot companies made by hedge funds: they shorted in order to cut off financing, then covered through predatory financing. In hindsight, I think the German approach is a starting point. Every short must disclose their short positions. Really, though, shorting is only "good" to punish fraud. In all other situations, I don't care if the end result is higher highs and lower lows.
Contrarian play: NBA warrants are down today. Ex-SPAC TLMD, which I shorted during the previous SPAC correction, is further down today. However, its warrants are still over $1.00. I'm waiting for NBA warrants to go *down* a little more between now and the merger, so I can buy more.
Any thoughts on HIMS or TLMD for healthcare tech plays?
TLMD will be posting their Q4 results at the end of the month, it’s a great price to get in at the moment $7.28 company details here https://investors.soctelemed.com do your own DD
TLMD 3/19 10c yolo don't even know what the company does